Browsing Category

65725 posts
Smartkem Reports Fourth Quarter and Full Year 2023 Financial Results

Smartkem Reports Fourth Quarter and Full Year 2023 Financial Results

MANCHESTER, England, March 28, 2024 /PRNewswire/ — Smartkem (OTCQB: SMTK), the developer…
Trina Solar Powers New Zealand's Largest Solar Farm with Integrated Module-Tracker Solution

Trina Solar Powers New Zealand's Largest Solar Farm with Integrated Module-Tracker Solution

KAITAIA, New Zealand, March 28, 2024 /PRNewswire/ — Trina Solar, a global…
Fueling Cybersecurity Innovation: Vivek Ramachandran Takes on Black Hat Arsenal Review Board Role with a Mission to Mentor and Motivate the Next Generation

Fueling Cybersecurity Innovation: Vivek Ramachandran Takes on Black Hat Arsenal Review Board Role with a Mission to Mentor and Motivate the Next Generation

SINGAPORE, March 28, 2024 /PRNewswire/ — In the field of cybersecurity, very…
Moomoo Announces the Moomoo Foundation Establishment, Hosts Financial Literacy Event with NYU's Economic Society

Moomoo Announces the Moomoo Foundation Establishment, Hosts Financial Literacy Event with NYU's Economic Society

JERSEY CITY, N.J., March 28, 2024 /PRNewswire/ — Moomoo, the intuitive investment…
Allprostar to Showcase its New Camping Series at Hong Kong Global Sources Sports & Outdoor Show 2024

Allprostar to Showcase its New Camping Series at Hong Kong Global Sources Sports & Outdoor Show 2024

XIAMEN, China, March 28, 2024 /PRNewswire/ — Allprostar(Xiamen) Industrial Co.,Ltd has over…
Canadian Solar Comments on Complaint Filed by Maxeon Solar

Canadian Solar Comments on Complaint Filed by Maxeon Solar

GUELPH, ON, March 28, 2024 /PRNewswire/ — Canadian Solar Inc. (the "Company", or…
Volvo Financial Services, JA Worldwide Expand Partnership, Bringing Financial Literacy Education to More Youth

Volvo Financial Services, JA Worldwide Expand Partnership, Bringing Financial Literacy Education to More Youth

GREENSBORO, N.C., March 28, 2024 /PRNewswire/ — Volvo Financial Services (VFS) today…
GenFleet and BeiGene Enter into Trial Collaboration for a Potentially First-in-class Combination Therapy to Initiate Phase Ib/II Study of GFH009 (CDK9 inhibitor) and BRUKINSA® (zanubrutinib) Treating Diffuse Large B Cell Lymphoma

GenFleet and BeiGene Enter into Trial Collaboration for a Potentially First-in-class Combination Therapy to Initiate Phase Ib/II Study of GFH009 (CDK9 inhibitor) and BRUKINSA® (zanubrutinib) Treating Diffuse Large B Cell Lymphoma

SHANGHAI, March 28, 2024 /PRNewswire/ — GenFleet Therapeutics, a clinical-stage biotechnology company focusing…